Literature DB >> 29701834

Adjustment of the GRACE score by 2-hour post-load glucose improves prediction of long-term major adverse cardiac events in acute coronary syndrome in patients without known diabetes.

Sudipta Chattopadhyay1, Anish George2, Joseph John3, Thozhukat Sathyapalan4.   

Abstract

Aims: Global Registry of Acute Coronary Events (GRACE) risk score (GRS), a powerful predictor of prognosis after acute coronary event (ACE), does not include a glucometabolic measure. We investigate whether 2 h post-load plasma glucose (2h-PG) could improve GRS based prognostic models in ACE patients without known diabetes mellitus (DM). Methods and results: A retrospective cohort study of 1056 ACE survivors without known DM who had fasting plasma glucose (FPG) and 2h-PG measured pre-discharge. Death and non-fatal myocardial infarction were recorded as major adverse cardiac events (MACE) during follow-up. GRS for discharge to 6 months was calculated. Cox proportional-hazards regression was used to identify predictors of event free survival. The predictive value of 2h-PG alone and combined with GRS was estimated using likelihood ratio test, Akaike's information criteria, continuous net reclassification improvement (NRI>0), and integrated discrimination improvement (IDI). During 40.8 months follow-up 235 MACEs (22.3%) occurred, more frequently in the upper 2h-PG quartiles. Two-hour PG, but not FPG, adjusted for GRS independently predicted MACE (hazard ratio 1.091, 95% confidence interval 1.043-1.142; P = 0.0002). likelihood ratio test showed that 2h-PG significantly improved the prognostic models including GRS (χ2 = 20.56, 1 df; P = 0.000). Models containing GRS and 2h-PG yielded lowest corrected Akaike's information criteria, compared to that with only GRS. 2h-PG, when added to GRS, improved net reclassification significantly (NRIe>0 6.4%, NRIne>0 24%, NRI>0 0.176; P = 0.017 at final follow-up). Two-hour PG, improved integrated discrimination of models containing GRS (IDI of 0.87%, P = 0.008 at final follow-up).
Conclusion: Two-hour PG, but not FPG, is an independent predictor of adverse outcome after ACE even after adjusting for the GRS. Two-hour PG, but not FPG, improves the predictability of prognostic models containing GRS.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29701834     DOI: 10.1093/eurheartj/ehy233

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

1.  Enrichment of the Postdischarge GRACE Score With Deceleration Capacity Enhances the Prediction Accuracy of the Long-Term Prognosis After Acute Coronary Syndrome.

Authors:  Shoupeng Duan; Jun Wang; Fu Yu; Lingpeng Song; Chengzhe Liu; Ji Sun; Qiang Deng; Yijun Wang; Zhen Zhou; Fuding Guo; Liping Zhou; Yueyi Wang; Wuping Tan; Hong Jiang; Lilei Yu
Journal:  Front Cardiovasc Med       Date:  2022-04-27

2.  Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.

Authors:  Giulia Ferrannini; Dirk De Bacquer; Pieter Vynckier; Guy De Backer; Viveca Gyberg; Kornelia Kotseva; Linda Mellbin; Anna Norhammar; Jaakko Tuomilehto; David Wood; Lars Rydén
Journal:  Cardiovasc Diabetol       Date:  2021-02-11       Impact factor: 9.951

3.  Nutritional Risk Index Improves the GRACE Score Prediction of Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Authors:  Xiao-Teng Ma; Qiao-Yu Shao; Qiu-Xuan Li; Zhi-Qiang Yang; Kang-Ning Han; Jing Liang; Hua Shen; Xiao-Li Liu; Yu-Jie Zhou; Zhi-Jian Wang
Journal:  Front Cardiovasc Med       Date:  2021-12-16

4.  Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Authors:  Shiqiang Xiong; Qiang Chen; Xu Chen; Jun Hou; Yingzhong Chen; Yu Long; Siqi Yang; Lingyao Qi; Hong Su; Wenchao Huang; Hanxiong Liu; Zhen Zhang; Lin Cai
Journal:  Cardiovasc Diabetol       Date:  2022-08-05       Impact factor: 8.949

5.  Glucose tolerance and markers of myocardial injury after an acute coronary syndrome: predictive role of the 1-h plus 2-h plasma glucose at the oral glucose tolerance test.

Authors:  Viola Zywicki; Paola Capozza; Paolo Caravelli; Stefano Del Prato; Raffaele De Caterina
Journal:  Cardiovasc Diabetol       Date:  2022-08-08       Impact factor: 8.949

6.  Prognostic value of myocardial salvage index assessed by cardiovascular magnetic resonance in reperfused ST-segment elevation myocardial infarction.

Authors:  Shiru Zhang; Quanmei Ma; Yundi Jiao; Jiake Wu; Tongtong Yu; Yang Hou; Zhijun Sun; Liqiang Zheng; Zhaoqing Sun
Journal:  Front Cardiovasc Med       Date:  2022-08-16

7.  Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control study.

Authors:  Ele Ferrannini; Lars Rydén; Elena Fortin; Giulia Ferrannini; Beatrice Campi; Linda Mellbin; Anna Norhammar; Per Näsman; Alessandro Saba
Journal:  Cardiovasc Diabetol       Date:  2022-09-23       Impact factor: 8.949

8.  Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.

Authors:  Maryam Kabootari; Samaneh Asgari; Seyedeh Maryam Ghavam; Hengameh Abdi; Fereidoun Azizi; Farzad Hadaegh
Journal:  J Transl Med       Date:  2021-06-30       Impact factor: 5.531

9.  Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c.

Authors:  Stelios Karayiannides; Catarina Djupsjö; Jeanette Kuhl; Claes Hofman-Bang; Anna Norhammar; Martin J Holzmann; Pia Lundman
Journal:  Cardiovasc Diabetol       Date:  2021-06-14       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.